SenesTech Q2 record revenue $625K (+36% YoY); Evolve sales up 94% YoY

SenesTech, Inc.

2025-Q2 EPS reported -$2.08 revenue$1,110,000

Revenue $625K (record), +36% YoY; Evolve Rodent Birth Control sales +94% YoY, now 83% of total revenue.
Gross margin improved to 65.4% (record) from 54.2% in Q2 2024; net loss flat at $1.6M.
Adjusted EBITDA loss narrowed to $1.4M from $1.5M YoY; cash balance $11.2M as of Aug 5, 2025, funding through 2027.
Expanded municipal pilots in NYC, Chicago, Boston, Baltimore, LA County, San Francisco; new automated mfg facility completed July 2025.
E-commerce revenue up 78% YoY; retail vertical grew 478% YoY via Bradley Caldwell partnership.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.